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Effect of antibiotic therapy on human fecal microbiota and the relation to the 
development of Clostridium difficile. 
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The gastrointestinal (GI) tract is a complex ecosystem. Recent studies have shown that the 
human fecal microbiota is composed of a consortium of microorganism. It is known that 
antibiotic treatment alters the microbiota, facilitating the proliferation of opportunists that 
may occupy ecological niches previously unavailable to them. It is therefore important to 
characterize resident microbiota to evaluate its latent ability to permit the development of 
pathogens such as Clostridium difficile. Using samples from 260 subjects enrolled in a 
previously published clinical study on antibiotic-associated diarrhea, we investigated the 
possible relationship between the fecal dominant resident microbiota and the subsequent 
development of C. difficile.  
We used molecular profiling of bacterial 16S rDNA coupled with PLS regression analysis. 
Fecal samples were collected on day 0 (D0) before antibiotic treatment and on day 14 (D14) 
after the beginning of the treatment. Fecal DNA was isolated and V6-to-V8 regions of the 16S 
rDNA were amplified by PCR with general primers and analyzed by Temporal Temperature 
Gradient gel Electrophoresis (TTGE). Main bacteria profiles were compared on the basis of 
similarity (Pearson correlation coefficient). The characteristics of the microbiota were 
determined using Partial Least Square (PLS) discriminant analysis model.  
Eighty seven TTGE profiles on D0 have been analyzed. The banding pattern was complex in 
all cases. The subsequent onset of C. difficile was not revealed by any clustering of TTGE 
profiles, but was explained up to 46% by the corresponding PLS model. Furthermore 6 zones 
out of the 438 dispatched from the TTGE profiles by the software, happened to be specific for 
the group of patients who acquired C. difficile. The first approach in the molecular 
phylogenetic analysis showed related sequences to uncultured clones. As for the 87 TTGE 
profiles on D14 no clustering could be found either, but the subsequent onset of C. difficile 
was explained up to 74.5% by the corresponding PLS model, thus corroborating the results 
found on D0. 
The non exhaustive data of the microbiota we found should be taken as the first step to assess 
the hypothesis of permissive microbiota. The PLS model was used successfully to predict C. 
difficile development. We found that important criteria in terms of main bacteria could be 
markedly considered as predisposing factors for C. difficile development. Yet the resident 
microbiota in case of Antibiotic-Associated Diarrhea (AAD) has still to be analyzed. Further 
more, these findings suggest that strategies reinforcing the ability of the fecal microbiota to 
resist to modifications would be of clinical relevance. 
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The gastrointestinal (GI) tract is a complex ecosystem generated by the alliance of GI 
epithelium, immune cells and resident microbiota. Experimental systems such as cell culture, 
germ-free animal models and intestinal isografts have demonstrated that each member of the 
GI ecosystem can follow a predetermined developmental pathway, even if isolated from the 
other components of the ecosystem. However, the presence of all three components is 
required for full physiological function [19]. Genetic or functional alterations of any one 
component of this ecosystem can result in a broken alliance and subsequent GI pathology. In 
this work, we will focus only on resident microbiota. 
In both health and disease, the colonic microbiota plays an important role in several areas of 
human physiology [15]. But this complex ecosystem is far from well known [29]. Culture-
independent 16S rDNA analyses have previously been used to examine the microbial 
diversity of the human gut [25] and explorative multivariable analyses of 16S rDNA data to 
study specific microbial communities [23].  
In a previous study Beaugerie et al. clarified the role of C. difficile in Antibiotic-Associated 
Diarrhea (AAD) in the community by prospectively studying a population of general-practice 
patients by means of routine screening for both C. difficile and the C. difficile toxin B. C. 
difficile was diagnosed by specific culture methods, and C. difficile toxin B was detected by 
its cytopathic effect. As for diarrhoea, it was scored with the help of validated visual support. 
Beaugerie’s study was the first to demonstrate a high rate of acquisition (2,7%) of toxin-
producing C. difficile during antimicrobial chemotherapy [2].  
C. difficile produces two major toxins (toxins A and B). These are thought to be primarily 
responsible for the virulence of the bacterium and the major contributors to the pathogenesis 
of antibiotic-associated gastrointestinal disease [4]. Following most antibiotic treatment there 
will be a point at which the impact on the normal gut microbiota depresses colonization 
resistance to C. difficile. The composition of the pre-existing microbiota may have an 
important role as well.  
Therefore, in view of literature data [7, 16, 21, 26], we judged as particularly promising to 
investigate the stool of the patients from Beaugerie’s previous work. Thus the aim of the 
present study was to test the hypothesis of predisposing factors slot in the resident microbiota.  
We used a genetic fingerprinting method. The characteristics of the microbiota were 
determined using Partial Least Square (PLS) discriminant analysis model. 
 
 3 
Methods 103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
113 
114 
115 
116 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
Patients. Our work is an explicative microbiological approach derived from a clinical study 
published elsewhere [2]. In short, 260 subjects enrolled in the latter study were adult out-
patients living in the Paris area, who were prescribed a 5-10 day course of antimicrobial 
chemotherapy. Criteria for enrolment were prescription by a general practitioner of a 5-10 day 
course of antibiotics and age 18 years or older. Potential candidates were excluded if they 
were institutionalized subjects, had received antibiotic treatment during the previous 2 
months, had been admitted to a hospital during the previous 6 months, had known human 
immunodeficiency virus infection, had any allergy, or had had a bout of diarrhea (more than 2 
loose stools per day) the day before enrolment. All patients had given their written consent. 
Each patient was asked to store the last stool before the beginning of the antibiotherapy (D0), 
and the stool 14 days after the beginning of the antibiotherapy (D14), in double-thickness 
containers, and to keep them in a refrigerator or in a cool place until collection by the study 
monitor [2]. The antibiotics given were classified into 3 classes: class 1, 
amoxicillin/clavulanic acid; class 2, other beta-lactam agents; class 3, non beta-lactam agents. 
Among the 260 patients, 11 acquired C. difficile. Among the 249 remaining patients without 
C. difficile, 38 were chosen because they developed an AAD and paired with patients with no 
AAD according to age range (within 10-years) and class of antibiotic. Thus our study 
included a total of 87 patients. The 11 patients, 3 men and 8 women, with acquired C. difficile 
were from 28 to 73 years old, 5 had taken Pristinamycin, 3 of them Amoxicillin, and 3 of 
them Amoxicillin/clavulanic acid. Because a typical initial antibiotic dose has no effect on 
dominant fecal microbiota for at least 8 to 10 hours (data not shown) we considered the 
dominant microbiota profile on D0 as the profile at equilibrium for each patient.  
 
DNA isolation, 16S rDNA amplification. Stool samples were collected in sterile tubes and 
immediately stored at -80°C until analysis. Total DNA was isolated from fecal samples by 
using the bead beating method [28]: Immediately after collection, total DNA was extracted 
from a 125-mg fecal sample aliquot and purified as described by Godon et al.[10] The DNA 
concentration and its integrity (size, >21 kb) were estimated by agarose gel electrophoresis 
(with 1.5% [wt/vol] agarose-1× Tris-borate-EDTA-1 ng of ethidium bromide ml 1). DNA 
was obtained from all samples (0.23 ± 0.1 µg/µl). DNA isolated was subsequently used as a 
template to amplify the V6 to V8 regions of the bacterial 16S rDNA with primers U968-GC 
(5’ CGC CCG GGG CGC GGC CCG GGC GGG GCG GGG GCA CGG GGG GAA CGC 
GAA GAA CCT TAC) and L1401 (5’ GCG TGT GTA CAA GAC CC ). PCR was performed 
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using Hot Star Taq DNA polymerase (Qiagen, Courtaboeuf, France). PCR mixtures of 50µL 
contained: 1X PCR Buffer, 1.5 mM Mg Cl
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2, 0.1 mM of each dNTP, 0.5 µM of primers U968-
GC and L1401, 2,5 U of Hot Star® Taq Polymerase, and approximately 1 ng of DNA. The 
samples were amplified in a Gene Amp PCR system 9700® (Perkin-Elmer, Nantes, France) 
by using the following program: 95°C for 15 min; 30 cycles of 94°C for 1min, 56°C for 1min, 
72°C for 1.5 min, and finally 72°C for 15 min.  
 
TTGE analysis of PCR amplicons Temporal Temperature Gradient gel Electrophoresis has 
been chosen (TTGE) as the culture independent method that allowed the main bacteria 
diversity to be compared among samples [27].  
The Dcode universal mutation detection system (Bio-Rad, Paris, France) was used for 
sequence-specific separation of PCR products. Electrophoresis was performed through a 1 
mm thick, 16 x16 cm polyacrylamide gel (8% wt/vol acrylamide-bisacrylamide, 7 M urea, 
1.25x % Tris-acetate EDTA (TAE), 55 µL and 550 µl of Temed and ammonium persulfate 
10%, respectively) using 7 liters of 1.25x TAE as electrophoresis buffer. Electrophoresis was 
run at a fixed voltage of 65 V for 969 min with an initial temperature of 66°C and a ramp rate 
of 0.2°C/h. For better resolution, voltage was fixed at 20 V for 5 min at the beginning of 
electrophoresis. Each well was loaded with 100-200 ng of amplified DNA plus an equal 
volume of 2x gel loading dye (0.05% bromophenol blue, 0.05% xylene cyanol, and 70% 
glycerol). As described earlier, a marker was used [7]. A temperature gradient from 66 to 
70°C (ramp rate of 0.2°C/hour) was applied during electrophoresis. After completion of 
electrophoresis, the gel was stained in a 30 µg/mL Sybr Green solution (Sybr Green I, Sigma-
Aldrich, St Quentin Fallavier, France), destained in 1.25x TAE, and analyzed using Quantity 
One® software of the Gel Doc 2000® system (Bio-Rad, Paris, France). Profiles were 
numerized and gray intensity recorded along a densitogram, each band giving rise to a peak.  
 
TTGE gel analysis. TTGE profiles were compared by using Gel Compare II software 
(Applied-Maths, Saint-Martens –Latem, Belgium). The analysis took into account the number 
of bands, their position on the gel, and their intensity. This software translates each TTGE 
profile into a densitometric curve, drawing a peak for each band (the area under the peak 
being proportional to the intensity of the band). A threshold area value was used to remove 
small peaks on the densitometric curves (these can be detected purely as a result of the 
amount of DNA applied to the gel). A marker consisting of a PCR amplicon mix of seven 
 5 
170 
171 
172 
173 
174 
175 
176 
177 
178 
179 
180 
181 
182 
183 
184 
185 
186 
187 
188 
189 
190 
191 
192 
193 
194 
195 
196 
197 
198 
199 
200 
201 
202 
203 
cloned rDNAs from different bacterial species was used to normalize the profiles. During this 
step the gel strips were stretched or shrunk so that the assigned bands on the reference 
patterns matched their corresponding reference positions. Similarity coefficients (Pearson 
correlation method) were then calculated for each pair of profiles, yielding a similarity matrix. 
A dendrogram was constructed from this matrix by using a UPGMA algorithm (unweighted 
pair group method using arithmetic averages) [14].  
 
Sequence analysis. Each electrophoregram consisted of a curve in which grey intensity = 
f(migration distance). The curves were digitized from the migration distances ranging from 1 
to 438 at steps of 1 interval, using the Gel Compare II software. Thus TTGE profiles were 
dispatched into zones of interest from which dominant bands were selected and excised for 
PCR and sequence analysis. Gel fragments were washed once in 200 µL PCR water and kept 
in 100 µL PCR water overnight at 4°C for diffusion. Ribosomal DNA fragments were then 
amplified from the dialyzate. The PCR reaction was as described above. The size and 
concentration of the amplicons were evaluated on 1.5% agarose gel containing EtBr. PCR 
products were sequenced by Genome Express (Meylan, France). Newly determined sequences 
were compared with those in GenBank by BlastN search (NCBI) and using the Ribosomal 
Database Project RDP II sequence-match facility (Michigan State University, USA) in order 
to ascertain their closest relatives.  
 
Multiple linear regression analysis. PLS-regression (PLSR) is a method for relating two 
data matrices, X and Y, by a linear multivariate model, but goes beyond traditional regression 
in that it models also the structure of X and Y. PLSR derives its usefulness from its ability to 
analyse data with many, noisy, collinear, and even incomplete variables in both X and Y. 
PLSR has the desirable property that the precision of the model parameters improves with the 
increasing number of relevant variables and observations. In the present study X variables are 
the TTGE profiles of dominant resident microbiota and variable Y is the presence or absence 
of C. difficile. Furthermore, this method allows the assumption that component X (dominant 
resident microbiota) is the component that is most relevant for predicting the variable Y 
(presence or absence of C. difficle) among others (sex, age, antibiotherapy). Relationships 
using PLS regression were established between dominant microbiota profiles and status of 
patients, using the SIMCA software, version 9.0 (UMETRI, Umeå, 
Sweden/www.umetrics.com). Each patient was given a code in which sex, stool sample, 
status, antibiotics and age were stated. First the TTGE profiles of each patient on D0 and D14 
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were established. Then they were analysed using the Gel Compare software. Finally, PLS 
regression was used to investigate the relations between TTGE profiles of patients (X 
variables) and the presence or absence of C. difficile (variable Y). The number of useful PLS 
components is determined by cross-validation (SIMCA-P 9.0, 2001). The X-loadings and the 
Y-loadings are noted w* and c, respectively. Groups of patients are presented as situated on a 
plane defined by PLS components. The explanatory performance of the model is evaluated 
using the R² coefficient which corresponds to the part of the variance of variable Y explained 
by the X variables [18].  
 
Results 
 
Storage of fecal samples. In the previously published clinical study the interval between stool 
passage and laboratory processing was 26.9 ± 8.3 h (range, 3 to 71 h). In order to test the 
stability of the dominant fecal microbiota, fecal samples from 4 healthy volunteers were 
analysed in parallel. Those samples were kept simultaneously at -80°C, 4°C, and 20°C for 24, 
48 and 72 hours and then analyzed by Temporal Temperature Gradient gel Electrophoresis 
(TTGE). Results are expressed as percentages of similarity of TTGE profiles after storage 
under the indicated conditions in comparison with an aliquot of the same sample stored at -
80°C (as the gold standard). After 24 hours, the percentages of similarity of TTGE profiles 
were of 88.6% ± 5.2 with storage at 4°C and 89.2% ± 1.8 with storage at 20°C. After 48 hours 
they were 89.1% ± 4 and 87.5% ± 1.9 respectively and after 72 hours they were 82% ± 7.4 
and 86% ± 3.3 respectively. 
 
Intra-individual analysis. 174 TTGE profiles were analyzed, from D0 and D14 for each of the 
87 patients studied. The banding pattern was complex in all cases. The dendrogram analysis 
showed that the TTGE profiles did not cluster according to presence or absence of C. difficile 
(UPGMA dendrogram not shown). Similarity percentages between D0 and D14 profiles for 
each of the 11 patients with acquired C. difficile, according to antibiotic classes, varied from i) 
0% (patient with AAD) and 90.8% (patient without AAD) for amoxicillin – clavulanic acid, 
ii) 41% (patient with AAD) and 71.3% (patient without AAD) for other beta-lactam agents 
and iii) 60.4% (patient with AAD) and 84.4% (patient without AAD) for non beta-lactam 
antibiotics. 
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Inter-individual analysis and PLS model: Relationships between the profiles included in the 
PLS model and the results of “acquired C difficile” are not easily established using a visual 
observation of the profiles. We calculated a PLS model that linked the 87 TTGE profiles of 
main bacteria (X variables) of patients and the subsequent onset of C. difficile (variable Y), 
first on D
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0 then on D14. The cross-validation led to R2 coefficient which denotes the 
percentage of variation. On D0 the corresponding PLS model explained 46% of the variation 
of the Y-matrix (development of C. difficile) (Fig. 1) and on D14 74.5% (Fig. 2).  
 
Sequence analysis: D0 TTGE profiles of the 11 patients with acquired C. difficile were 
compared on the same gel (Fig. 3). The analysis of the 438 zones dispatched from TTGE 
profiles by the software, showed that only 6 were specific for the group of patients with 
acquired C. difficile. From those 6 zones of interest, 7 main bands have been selected taking 
into account their optical density and distinctiveness. To gain insight into the phylogenetic 
positions of those amplicon DNA, they were extracted from the gel and sequenced. The 
sequences showed the highest similarity with sequences derived from different Clostridium 
clusters of the low guanine+cytosine (G+C) gram positive species [5]. The average 
determined length of the DNA sequences was 500 bases, and phylogenetic analysis was based 
on 400 to 450 aligned homologous nucleotides (corresponding to positions 900 to 1400 in 
Escherichia coli 16S rDNA). Using the same approach, 2 zones of interest were identified at 
D14. Three bands were selected, extracted and sequenced. The characteristics of the 7 
extracted sequences of D0 and of the 3 extracted sequences of D14 are shown in table 1 with 
the origin (fecal sample), sequence length (370-417), closest relative identification and 
percentage of identification. They all belong to Clostridiales order, Clostridiaceae, 
Eubacterium and Lachnospiraceae family.  
 
Discussion 
Our results support the concept of “permissive” microbiota. Using molecular profiling of 
bacterial 16S rDNA coupled with PLS regression analysis, we found that important criteria in 
terms of main bacteria of the fecal microbiota could be considered as predisposing factors for 
C. difficle development. We did not intend to sequence all implicate bacteria species. The 
studied patients were adult out-patients living in the Paris area. We assumed that all were 
exposed equally to C. difficile from the environment. The PLS regression analysis gave a 
predictive ability of 46% for the resident microbiota of those patients who developed a 
C.difficile after an antibiotherapy. These results explain the development of C.difficle 
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following antibiotic treatment and corroborate a metaproteomic approach to link biological 
functions to gene sequences. Furthermore, these findings suggest that strategies reinforcing 
the ability of the resident microbiota to resist to modifications would be of clinical relevance.  
Recent culture-independent molecular studies on healthy individuals have shown that the 
intestinal microbiota is specific to the host and resistant to modification over time [27]. 
Although, the difficulty to identify the exact profile at equilibrium has already been discussed 
[6], to take into account every patient’s data including factors such as age, sex, clinical and/or 
antibiotherapy, is rather difficult. It needs the help of an abstract model that uses 
mathematical language to describe the behavior of the system by a set of variables and a set of 
equations that establish relationships between the variables. PLS-regression is a particular 
type of multivariate analysis which uses the two-block predictive PLS model to model the 
relationship between two matrices. PLS-regression derives its usefulness from its ability to 
analyze data with many, noisy, collinear, and even incomplete variables in both X and Y. 
PLS-regression has the advantageous property that the precision of the model parameters 
improves with the increasing number of relevant variables and observations [8]. Thus we 
chose PLS-regression for relating the resident microbiota to C. difficile development. PLS-
regression has been used in various disciplines such as chemistry, economics, medicine, 
pharmaceutical science and microbiology [13, 18, 20]. The PLS-regression analysis of the 
resident microbiota on D0 gives one significant component explaining 46% of the Y-variance. 
Our analysis shows that the data are clustered: The resident microbiota from patients with 
later C. difficile development deviates from the main cluster. In addition PLS-regression 
detected the variable that is highly linked to variable Y (acquired C. difficile) among a large 
number of X variables (TTGE profile, age, sex and class of antibiotic) as applied to a large 
number of observations. In our model the variable X (=TTGE profiles) had been detected 
based on its significance, other X variables (age, sex and class of antibiotic) were not relevant 
although a specific study with the different antibiotics would be warranted. 
Thus the present report provides evidence for predisposing factors in resident microbiota. 
Such scoring functions should aid in the identification of putative group of bacteria. Moreover 
the model could be used to predict the inclusion of new patients by incorporating their TTGE 
profiles into the model. Therefore, more information could be obtained from TTGE profiles 
than those given by densitometric analyses. This model enabled the parameters affecting the 
distribution of the microbiota to be examined. Nevertheless the molecular determinants and 
host specificity have yet to be identified. 
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Operational Taxonomic Unit or molecular species is defined as a set of sequences with less 
than 2% divergence in 400-450 aligned homologous nucleotides [25]. Thus most of the 
sequences identified in this work were related to uncultured bacterium clones (99-98%) from 
Clostridiales order. Among the anaerobes the Clostridiales order are known to have a strong 
catalytic activity.  
The non exhaustive data of the microbiota we found show species only from Clostridiales 
order, Clostridiaceae, Eubacterium and Lachnospiraceae family. This is not surprising since 
novel or yet uncultured species are most often identified upon characterization of fecal 
microbiota using cloned 16S rDNA genes librairies [11]. Recent culture-independent studies 
have shown that approximately 70% of the dominant human gut microorganisms have not 
been isolated and described [3].  
Interestingly, after substractive densitometric analyses on D0 for the selected band 1, we 
found that it was common in 10 out of the 11 TTGE profiles of the selected patients and only 
2 out of the 76 others. Furthermore, among the 11 patients with acquired C. difficile, 5 
developed AAD. They clustered separately from the 6 patients without AAD on D0 as well as 
on D14, suggesting two different “sub-groups” of dominant microbiota. These results’ 
analyses are consistent with our hypothesis and merit confirmation. This will be tested with 
patients who developed AAD. 
Within D14 of antibiotherapy, the human fecal microbiota of patients was markedly 
modulated. The alterations observed here (0% patient with AAD and 90.8% patient without 
AAD) in the structure of the microbiota upon amoxicillin – clavulanic acid treatment are 
important enough to suggest two groups of patients. It had been determined that upon natural 
oscillations of dominant fecal microbiota TTGE profiles would remain within 90% of 
similarity with the equilibrium state over a period of two years in one volunteer [24]. Thus, 
these observations suggest the occurrence of a specific resistant microbiota to amoxicillin – 
clavulanic acid and would warrant confirmation.   
From the 5 patients with AAD one was found neither toxinogenic nor with toxin. Thus, in this 
case, C. difficile could not be considered as cause of diarrhea, although a negative search for 
toxin and/or toxinogenesis obviously does not constitute final proof for the absolute lack of C. 
difficile spore in the microbiota. 
The dendrogram analysis showed that the TTGE profiles did not cluster according to presence 
or absence of C. difficile. But the PLS –regression model explained 46% of the variation of 
the Y-matrix (development of C.difficile). This study assessed for each individual, the 
significance of resident microbiota but did not intend to determine the composition of the 
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dominant fecal microbiota in terms of bacterial genera or species. The new sequences found 
in the genus Clostridium indicate the importance of this genus inside the microbiota and its 
putative role in development of pathogens [7]. Molecular analyses of the bacterial microbiota 
based on 16S rDNA have attracted attention as reliable methods for detection and 
identification of bacterial species [1, 12, 17]. Techniques such as temporal temperature 
gradient gel electrophoresis are attractive because they are conducive to high throughput 
studies. TTGE successfully differentiates bacterial gene fragments of the same size but 
different thermal stability. The uses and limits of TTGE in microbial ecology have already 
been explored [7, 22]. The ability to apply statistical methods makes denaturing gel 
electrophoresis fingerprinting techniques such as TTGE tools with great potential [7, 9]. Only 
the dominant fraction of the fecal microbiota is assessed using the PCR-TTGE technique, as 
applied here, with universal primers. The complexity of the profiles observed by TTGE will 
represent the most prevalent species.  
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Table 1: Data of the sequences: origin, sequence length, closest relative identification 
(accession number), % identity. 
447 
448 
449 
450 
 
 
N° 
extract.
bande 
Accesion 
Number 
 
Origin Sequence 
length 
(letter) 
Closest 
relative 
Phylum/class of the 
closest relative 
% 
Iden
tity 
1 EU196222 Fecal 
sample 
Individual 
395 Uncultured 
bacterium 
 
Genus Ruminococcus, 
(DQ802748) 
99 
2 EU196223 Fecal 
sample 
Individual 
394 Uncultured 
bacterium 
 
Unclassified_Clostridiale
s (AY984391) 
99 
3 EU196224 Fecal 
sample 
Individual 
395 Clostridium Clostridium sp. 
(AJ582080) 
98 
4 EU196225 Fecal 
sample 
Individual 
391 Uncultured 
bacterium 
 
Genus Ruminococcus 
(DQ905852) 
99 
5 EU196226 Fecal 
sample 
Individual 
370 Uncultured 
bacterium 
 
Genus Ruminococcus 
(AM277309) 
99 
6 EU196227 Fecal 
sample 
Individual 
386 Uncultured 
bacterium 
 
Genus Dorea/ family 
Clostridiaceae 
(DQ802652) 
99 
7 EU196228 Fecal 
sample 
Individual 
394 Uncultured 
bacterium  
 
Genus Eubacterium 
(AM275432) 
91 
8 EU196229 Fecal 
sample 
Individual 
405 Uncultured 
bacterium 
 
 unclassified_Lachnospir
aceae  
(AY235653) 
100 
9 EU196230 Fecal 
sample 
Individual 
417 Uncultured 
bacterium 
 
Genus Ruminococcus  
10 EU196231 Fecal 
sample 
Individual 
389 Uncultured 
bacterium 
 
Genus Ruminococcus 
Uncultured Firmicutes 
(EF071261) 
94 
451 
452 
453 
454 
455 
456 
457 
458 
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Legends to figures 459 
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Figure 1: 3D representation of the PLS regression model showing relationship between 
TTGE profiles of dominant species before any antibiotic treatment (D0) and the subsequent 
onset of C. difficile. The corresponding model explained 46% of the estimated modification. 
Positions of the D0 TTGE profiles of patients who acquired C. difficile are indicated in this 
3D representation, by rectangles, position of the D0 TTGE profiles of others are indicated by 
triangles. 
 
Figure 2: 3D representation of the PLS regression model showing relationship between 
TTGE profiles of dominant species 14 days after the antibiotic treatment (D14) and the 
subsequent onset of C. difficile. The corresponding model explained 74.5% of the estimated 
modification. Positions of the D14 TTGE profiles of patients who acquired C. difficile are 
indicated in this 3D representation, by rectangles, position of the D14 TTGE profiles of others 
are indicated by triangles.  
 
Figure 3: Temporal temperature gradient gel electrophoresis of 16S rDNA amplicons 
(amplified with universal primers for the V6-V8 region of the gene) of fecal samples obtained 
at day 0, before any antibiotherapy, from the 11 patients who acquired a C. difficile after the 
antibiotherapy. 
 
Figure 4:  Example of Temporal temperature gradient gel electrophoresis of 16S rDNA 
amplicons (amplified with universal primers for the V6-V8 region of the gene) of fecal 
samples from patients 6 and 9, who acquired C. difficile after the antibiotherapy, at Day 0 and 
Day 14. 
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